Key result
Beta blockers and risk stratification remain standard post-MI, while routine anticoagulants or antiplatelets lack evidence.
Why the study?
Management strategies for postinfarction patients require identification and treatment of those at risk for future coronary morbidity or mortality.
What is the recommended management strategy for postinfarction patients to reduce future coronary morbidity or mortality?
What is the recommended management strategy for postinfarction patients to reduce future coronary morbidity or mortality?
This review outlines a comprehensive approach to post-MI management, emphasizing risk stratification, lifestyle modification, and beta-blocker therapy.
May guide post-MI risk assessment; leaves open validation against contemporary imaging and therapies.
Management of the postinfarction patient should be directed toward identifying and treating individuals at risk of future coronary morbidity or mortality. The history, physical examination, resting ECG, and chest film, supplemented with ambulatory electrocardiographic monitoring, noninvasive assessment of left ventricular function, graded exercise testing, and sometimes angiography allow stratification of patients into high- and low-risk subgroups. A program of exercise training, risk factor modification, and prophylactic therapy with beta blockers would be warranted in most patients. Use of antiarrhythmic agents may alter prognosis in certain subgroups. Evidence is currently insufficient to warrant routine use of anticoagulant or antiplatelet agents in the postinfarction patient.
No takes yet. Share an insight, caveat, or question.
Esterbrooks et al. (1983) conducted a review in Myocardial infarction. Postinfarction management (risk stratification, beta blockers, exercise) was evaluated. Management of post-myocardial infarction patients involves risk stratification and prophylactic therapy with beta blockers, while routine use of anticoagulants or antiplatelets lacks sufficient evidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: